Jennison Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.65B | Sell |
5,060,878
-72,798
| -1% | -$73.8M | 3.2% | 7 |
|
|
2025
Q4 | $5.52B | Buy |
5,133,676
+937,204
| +22% | +$896M | 3.31% | 7 |
|
|
2025
Q3 | $3.2B | Sell |
4,196,472
-1,251,164
| -23% | -$931M | 1.86% | 12 |
|
|
2025
Q2 | $4.25B | Buy |
5,447,636
+226,620
| +4% | +$176M | 2.52% | 8 |
|
|
2025
Q1 | $4.31B | Buy |
5,221,016
+424,693
| +9% | +$353M | 3.02% | 8 |
|
|
2024
Q4 | $3.7B | Sell |
4,796,323
-2,151,072
| -31% | -$1.78B | 2.25% | 9 |
|
|
2024
Q3 | $6.15B | Sell |
6,947,395
-285,593
| -4% | -$257M | 3.82% | 7 |
|
|
2024
Q2 | $6.55B | Sell |
7,232,988
-233,514
| -3% | -$187M | 4.2% | 6 |
|
|
2024
Q1 | $5.81B | Sell |
7,466,502
-131,110
| -2% | -$93.3M | 3.88% | 5 |
|
|
2023
Q4 | $4.43B | Sell |
7,597,612
-810,001
| -10% | -$473M | 3.3% | 5 |
|
|
2023
Q3 | $4.52B | Sell |
8,407,613
-173,825
| -2% | -$89.6M | 3.83% | 6 |
|
|
2023
Q2 | $4.02B | Buy |
8,581,438
+7,274
| +0.1% | +$3.05M | 3.3% | 6 |
|
|
2023
Q1 | $2.94B | Sell |
8,574,164
-1,854,917
| -18% | -$626M | 2.7% | 6 |
|
|
2022
Q4 | $3.82B | Buy |
10,429,081
+364,339
| +4% | +$129M | 3.87% | 3 |
|
|
2022
Q3 | $3.25B | Sell |
10,064,742
-293,324
| -3% | -$92.9M | 3.24% | 5 |
|
|
2022
Q2 | $3.36B | Buy |
10,358,066
+2,456,760
| +31% | +$737M | 3.35% | 5 |
|
|
2022
Q1 | $2.26B | Sell |
7,901,306
-1,254,308
| -14% | -$323M | 1.67% | 14 |
|
|
2021
Q4 | $2.53B | Sell |
9,155,614
-708,902
| -7% | -$180M | 1.6% | 15 |
|
|
2021
Q3 | $2.28B | Buy |
9,864,516
+953,521
| +11% | +$235M | 1.47% | 20 |
|
|
2021
Q2 | $2.05B | Buy |
8,910,995
+3,470,858
| +64% | +$697M | 1.36% | 24 |
|
|
2021
Q1 | $1.02B | Buy |
5,440,137
+3,561,294
| +190% | +$697M | 0.74% | 39 |
|
|
2020
Q4 | $317M | Sell |
1,878,843
-2,701,830
| -59% | -$403M | 0.23% | 57 |
|
|
2020
Q3 | $678M | Sell |
4,580,673
-3,482,699
| -43% | -$539M | 0.55% | 47 |
|
|
2020
Q2 | $1.32B | Sell |
8,063,372
-2,128,680
| -21% | -$327M | 1.2% | 23 |
|
|
2020
Q1 | $1.41B | Buy |
10,192,052
+5,679,574
| +126% | +$780M | 1.72% | 18 |
|
|
2019
Q4 | $593M | Buy |
4,512,478
+3,157,292
| +233% | +$366M | 0.6% | 44 |
|
|
2019
Q3 | $152M | Sell |
1,355,186
-218,457
| -14% | -$24.3M | 0.16% | 77 |
|
|
2019
Q2 | $174M | Sell |
1,573,643
-2,077,373
| -57% | -$245M | 0.17% | 72 |
|
|
2019
Q1 | $474M | Buy |
3,651,016
+225,592
| +7% | +$27.4M | 0.47% | 48 |
|
|
2018
Q4 | $396M | Buy |
3,425,424
+1,280,878
| +60% | +$143M | 0.44% | 49 |
|
|
2018
Q3 | $230M | Buy |
2,144,546
+242,577
| +13% | +$24.3M | 0.21% | 59 |
|
|
2018
Q2 | $162M | Buy |
1,901,969
+8,272
| +0.4% | +$679K | 0.16% | 82 |
|
|
2018
Q1 | $147M | Sell |
1,893,697
-383,990
| -17% | -$30.9M | 0.15% | 92 |
|
|
2017
Q4 | $192M | Buy |
2,277,687
+270,921
| +14% | +$23.1M | 0.19% | 70 |
|
|
2017
Q3 | $172M | Buy |
2,006,766
+59,705
| +3% | +$4.9M | 0.18% | 77 |
|
|
2017
Q2 | $160M | Buy |
1,947,061
+237,342
| +14% | +$19.4M | 0.17% | 86 |
|
|
2017
Q1 | $144M | Sell |
1,709,719
-25,691
| -1% | -$2.06M | 0.15% | 98 |
|
|
2016
Q4 | $128M | Buy |
1,735,410
+441,381
| +34% | +$32.9M | 0.14% | 117 |
|
|
2016
Q3 | $104M | Sell |
1,294,029
-12,057
| -0.9% | -$965K | 0.11% | 154 |
|
|
2016
Q2 | $103M | Buy |
1,306,086
+756,569
| +138% | +$57M | 0.11% | 158 |
|
|
2016
Q1 | $39.6M | Sell |
549,517
-610
| -0.1% | -$46.2K | 0.04% | 321 |
|
|
2015
Q4 | $46.4M | Sell |
550,127
-517,393
| -48% | -$42.9M | 0.05% | 296 |
|
|
2015
Q3 | $89.3M | Buy |
1,067,520
+14,615
| +1% | +$1.23M | 0.09% | 198 |
|
|
2015
Q2 | $87.9M | Buy |
1,052,905
+8,569
| +0.8% | +$653K | 0.08% | 226 |
|
|
2015
Q1 | $75.9M | Sell |
1,044,336
-7,154
| -0.7% | -$509K | 0.07% | 256 |
|
|
2014
Q4 | $72.5M | Buy |
+1,051,490
| New | +$71M | 0.07% | 261 |
|
|
2014
Q3 | – | Sell |
-61,216
| Closed | -$3.81M | – | 739 |
|
|
2014
Q2 | $3.81M | Buy |
61,216
+11,206
| +22% | +$669K | ﹤0.01% | 523 |
|
|
2014
Q1 | $2.94M | Sell |
50,010
-18,373
| -27% | -$1.03M | ﹤0.01% | 557 |
|
|
2013
Q4 | $3.49M | Buy |
68,383
+6,147
| +10% | +$308K | ﹤0.01% | 521 |
|
|
2013
Q3 | $3.13M | Buy |
+62,236
| New | +$3.26M | ﹤0.01% | 536 |
|
Other funds holding LLY
VCM
VPM
Jennison Associates's LLY Position: Q1 2026 in Review
Jennison Associates reduced its Eli Lilly (LLY) stake by 1.4% in Q1 2026, selling an estimated $73.8M and leaving 5,060,878 shares worth $4.65B. The position accounts for 3.2% of the portfolio, ranked #7.
Jennison Associates first reported a position in LLY in Q3 2013 and has held it in 50 quarters since. The position peaked at $6.55B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Jennison Associates held 5,060,878 shares of Eli Lilly worth $4.65B as of Q1 2026.
- Jennison Associates sold 72,798 Eli Lilly shares in Q1 2026, an estimated $73.8M.
- Eli Lilly made up 3.2% of Jennison Associates's portfolio in Q1 2026, its #7 holding.
- Jennison Associates first reported a position in Eli Lilly in Q3 2013 and has held it in 50 quarters since.
- Jennison Associates's Eli Lilly position peaked at $6.55B in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.